Senestech Inc

Senestech Inc(SNES)の株式分析

$0.750

+0.066 (+8.81%)終値時点

Loading chart…
高値
0.763
始値
0.680
出来高加重平均価格
0.73
出来高
500.67K
時価総額
2.94M
安値
0.680
売買代金
365.99K
EV/EBITDA(TTM)
-0.11

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

senestech.com

AI分析 of Senestech Inc (SNES)

中立

Senestech Inc shows potential for future growth, but current indicators suggest it may not be a good buy right now. The stock has a current price of $0.65, with a 1-year change of -83.99%, indicating significant decline. The RSI is at 38.654, suggesting it is nearing oversold territory, but the forward P/E ratio of 3.399 indicates potential undervaluation. However, the risk remains high due to a net income loss of $2.06 million in Q1 2026 and a YTD change of -70.73%.

アナリスト評価(2)

上値余地 +1233.33%
買い
2 買い
0 中立
0 売り
現在: 0.75
安値
10.00
平均
10.00
高値
10.00

HC Wainwright & Co.

2024-12-13

目標株価

$10

強い買い

HC Wainwright & Co.

2024-12-12

目標株価

$10

強い買い

HC Wainwright & Co.

2024-05-14

目標株価

$3.5

強い買い

HC Wainwright & Co.

2023-12-28

目標株価

$3.5

強い買い

HC Wainwright & Co.

2023-05-24

目標株価

$48

強い買い

バリュエーション指標

Senestech Inc(SNES)の現在の予想PERは3.40で、5年平均は-0.40です。

予想PER

大幅な割高
5年平均 P/E
-0.40
現在のP/E
3.40
割高
1.15
割安
-1.95

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-0.44
現在のEV/EBITDA
-0.11
割高
0.60
割安
-1.49

予想PSR

適正
5年平均 P/S
2.30
現在のP/S
0.81
割高
4.60
割安
0.00

Alphio AI による SNES の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%SNES

$3.91

シナリオ価格

基

基本

基本 · 50%SNES

$3.75

シナリオ価格

弱

弱気

弱気 · 25%SNES

$3.33

シナリオ価格

イベントタイムライン

2026-10-19 (ET)

09:30:00

SenesTech Reports Evolve Rat Control Pilot Results

2026-10-15 (ET)

08:30:00

SenesTech Achieves First $1M Revenue in Q3

2026-09-23 (ET)

09:00:00

SenesTech Launches Evolve Products on Grove Collaborative

2026-08-31 (ET)

09:00:00

SenesTech Reduces Rodent Activity by 43% in Massachusetts

2026-08-03 (ET)

09:00:00

SenesTech's Online Subscription Customers More Than Doubled

ニュース

SNES のよくある質問 — Alphio AI が回答

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

Senestech Inc shows potential for future growth, but current indicators suggest it may not be a good buy right now. The stock has a current price of $0.65, with a 1-year change of -83.99%, indicating significant decline. The RSI is at 38.654, suggesting it is nearing oversold territory, but the forward P/E ratio of 3.399 indicates potential undervaluation. However, the risk remains high due to a net income loss of $2.06 million in Q1 2026 and a YTD change of -70.73%.

2 analysts cover SNES: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める